Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.4580
-0.0120 (-2.55%)
Dec 5, 2025, 4:00 PM EST - Market closed

Impact BioMedical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
4817----
Upgrade
Enterprise Value
7125----
Upgrade
Last Close Price
0.461.45----
Upgrade
PB Ratio
-2.31----
Upgrade
Debt / Equity Ratio
-2.581.230.430.310.310.03
Upgrade
Asset Turnover
0.00--0.00--
Upgrade
Quick Ratio
0.000.200.0100.000.07
Upgrade
Current Ratio
0.040.250.030.010.020.10
Upgrade
Return on Equity (ROE)
-346.99%-139.55%-14.46%-19.99%-4.52%-3.89%
Upgrade
Return on Assets (ROA)
-7.68%-6.54%-5.53%-4.13%-3.81%-2.32%
Upgrade
Return on Capital (ROIC)
-8.84%-7.52%-6.07%-4.47%-4.18%-2.61%
Upgrade
Return on Capital Employed (ROCE)
71.40%-32.30%-12.80%-9.50%-7.30%-1.90%
Upgrade
Earnings Yield
-92.22%-148.12%----
Upgrade
FCF Yield
-8.43%-23.49%----
Upgrade
Buyback Yield / Dilution
80.23%82.14%14.54%0.00%--
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q